Abstract
BackgroundAdoptive cell therapy (ACT) with tumor-reactive T cells has shown consistent clinical efficacy. We evaluated the response to ACT in combination with interferon alpha (IFNa) preconditioning in patients with stage...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have